Neurotrophin receptor modulator

This page covers all Neurotrophin receptor modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TrkA, p75NTR.

Targets

TrkA, p75NTR

Phase 3 pipeline (1)

• BR-TD-1001 · Boryung Biopharma Co., Ltd. · Neurology
  BR-TD-1001 is a dual-acting compound that modulates both TrkA and p75NTR signaling pathways involved in neuroinflammation and neurodegeneration.

Patent intelligence

• neurotrophin receptor modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates